Rh(I) and Ir(I) Complexes with Hindered Thiolates
Organometallics, Vol. 25, No. 18, 2006 4387
purified by column chromatography on silica gel by using CH2-
Cl2/petroleum ether (1:1) and CH2Cl2/MeOH (99:1) solvent systems
to yield pure 6-tert-butylpyridine-2-thiol (3.938 g, 89%). 1H NMR
(CDCl3, 300.08 MHz, 30 °C): δ 10.54 (br s, 1 H), 7.38 (d, J )
8.7 Hz, 1 H), 7.27 (t, J ) 7.2 Hz, 1 H), 6.57 (d, J ) 7.2 Hz, 2 H),
1.33 (s, 9 H). 13C{1H} NMR (CDCl3, 125.7 MHz, 30 °C): δ 158.9,
138.1, 131.1, 109.3, 35.2, 29.3. Anal. Calcd for C9H13NS
(167.27): C, 64.62; H, 7.83; N, 8.37. Found: C, 65.02; H, 7.87;
N, 8.01.
CH, COD), 3.83 (br s, 1 H, dCH, COD), 3.58 (br m, 1 H, dCH,
COD), 3.29 (s, 3 H, N-CH3), 3.27 (s, 3 H, N-CH3), 3.06 (br s, 1
H, dCH, COD), 2.74 (br s, 2 H, >CH2, COD), 2.49 (br s, 1 H,
>CH2, COD), 2.17-1.88 (br m, 7 H, >CH2, COD), 1.51 (br s, 11
H, CH2, COD, and CH3, tBu), 1.04 (br s, 9 H, CH3, tBu). 13C{1H}
NMR (CD2Cl2, 75.46 MHz, 25 °C): δ 151.2 (SC), 142.6 (C4), 116.2
(C5), 81.2 (d, JC-Rh ) 11.92 Hz, dCH, COD), 33.9 (N-CH3), 32.3
t
t
(C, Bu), 31.6 (CH2, COD), 30.4 (CH3, Bu). 13C{1H} APT NMR
(CD2Cl2, 75.47 MHz, -95 °C): δ 149.6 (SC), 149.3 (SC), 146.5
(C4), 140.3 (C4), 33.9 (N-CH3), 33.1 (N-CH3), 31.6 (CH2, COD)
Representative Procedure for the Synthesis of [M(HetS)-
(COD)]n Complexes. Synthesis of [Rh(µ-tBu-PyS)(COD)]2 (1).
[Rh(µ-OMe)(COD)]2 (0.200 g, 0.413 mmol) and 6-tert-butylpyri-
dine-2-thiol (0.138 g, 0.826 mmol) were dissolved in dry CH2Cl2
(4 mL) to give immediately an orange solution. The mixture was
stirred 3.5 h at room temperature and concentrated under vacuum
to 1-2 mL. Addition of cold MeOH (3 mL) to the concentrated
solution gave the product as a yellow microcrystalline solid, which
was filtered off, washed with cold MeOH (2 × 5 mL), and vacuum-
t
t
t
31.0 (C, Bu), 30.5 (CH3, Bu), 28.6 (CH3, Bu). MS [FAB+ m/z
(%)]: 760 (20) [M+], 652 (31) [M+ - COD]. Anal. Calcd for
C32H50N4S2Rh2 (760.71): C, 50.52; H, 6.63; N, 7.37; S, 8.43.
Found: C, 50.25; H, 6.53; N, 7.32; S, 8.66.
Synthesis of [Ir(µ-Me-tBu-ImS)(COD)]2 (8). Following the
general procedure, [Ir(µ-OMe)(COD)]2 (0.273 g, 0.413 mmol) and
1-methyl-4-tert-butylimidazole-2-thiol (0.140 g, 0.826 mmol) were
1
used to prepare 8 (0.352 g, 91%). H NMR (toluene-d8, 300.12
1
dried (0.261 g, 84%). H NMR (CD2Cl2, 300.13 MHz, 25 °C): δ
MHz, 70 °C): δ 6.06 (s, 2 H, H5), 4.46 (br s, 8 H, dCH, COD),
2.94 (br s, 6 H, N-CH3), 2.36 (br s, 8 H, CH2, COD), 1.66 (br s,
8 H, CH2, COD), 1.40 (br s, 24 H, CH3, tBu).1H NMR (toluene-d8,
300.12 MHz, 25 °C), selected resonances: δ 5.99 (s, 2 H, H5),
7.38 (t, J ) 7.7 Hz, 2 H, H4), 7.16 (d, J ) 7.5 Hz, 2 H, H3), 7.04
(d, J ) 7.6 Hz, 2 H, H5), 4.84 (br s, 8 H, dCH, COD), 2.42 (br m,
8 H, CH2, COD), 1.96 (br m, 8 H, CH2, COD), 1.32 (s, 18 H, CH3,
tBu). 1H NMR (CD2Cl2, 300.13 MHz, -70 °C): δ 7.34 (t, J ) 7.7
Hz, 2 H, H4), 7.06 (d, J ) 7.6 Hz, 2 H, H3), 6.99 (d, J ) 7.7 Hz,
2 H, H5), 4.98 (br s, 4 H, dCH, COD), 4.43 (br s, 4 H, dCH,
COD), 2.33 (br m, 8 H, CH2, COD), 1.87 (br m, 8 H, CH2, COD),
1
4.63 (br s, 8 H, dCH, COD). H NMR (toluene-d8, 300.12 MHz,
-60 °C): δ 5.88 (br s, 1 H, dCH, COD), 5.75 (s, 1 H, H5), 5.62
(s, 1 H, H5), 5.58 (br s, 1 H, dCH, COD), 5.40 (br s, 1 H, dCH,
COD), 4.74 (br s, 1 H, dCH, COD), 4.23 (br s, 1 H, dCH, COD),
4.11 (br s, 1 H, dCH, COD), 3.60 (br s, 1 H, dCH, COD), 3.40
(br s, 1 H, dCH, COD), 2.92 (br s, 5 H, N-CH3 and CH2, COD),
2.72 (br s, 1 H, CH2, COD), 2.54 (s, 3 H, N-CH3), 2.44 (br m, 5
H, CH2, COD), 1.89 (br m, 2 H, CH2, COD), 1.64 (br s, 9 H, CH3,
tBu), 1.32 (br s, 15 H, CH2, COD and CH3, tBu). 1H NMR (CDCl3,
400.16 MHz, 25 °C), selected resonances: δ 6.42 (s, 2 H, H5),
t
1.20 (s, 18 H, CH3, Bu). 13C{1H} NMR (CD2Cl2, 75.46 MHz, 25
°C): δ 169.9 (SC), 158.9(C6), 136.3 (C5), 126.9 (C4), 116.4 (C3),
80.3 (d, JC-Rh ) 11.9 Hz, dCH, COD), 38.2 (C, tBu), 31.6 (CH2,
COD) 30.2 (CH3, tBu). 13C{1H} APT NMR (CD2Cl2, 75.47 MHz,
-70 °C): δ 168.7 (SC), 157.3 (C6), 135.6 (C5), 125.7 (C4), 115.5
(C3), 81.3 (br s, dCH, COD), 77.9 (br s, dCH, COD), 37.3 (C,
tBu), 30.8 (CH2, COD), 29.2 (CH3, tBu). MW: found 717.6 (calcd
1
4.47 (br s, 8 H, dCH, COD), 3.42 (s, 6 H, N-CH3). H NMR
754.69). MS [FAB+ m/z (%)]: 755 (55) [MH]+, 646 (100) [M+
COD]. Anal. Calcd for C34H48N2S2Rh2 (754.69): C, 54.11; H, 6.41;
-
(CDCl3, 300.12 MHz, -55 °C): δ 6.47 (s, 1 H, H5), 6.42 (s, 1 H,
H5), 4.82 (br m, 2 H, dCH, COD), 4.68 (br m, 1 H, dCH, COD),
4.13 (br m, 2 H, dCH, COD), 3.51 (br m, 1 H, dCH, COD), 3.40
(s, 3 H, N-CH3), 3.37 (s, 3 H, N-CH3), 3.12 (br s, 1 H, dCH,
COD), 3.04 (br m, 1 H, dCH, COD), 2.48 (br m, 2 H, CH2, COD),
2.31 (br m, 2 H, CH2, COD), 2.01 (br m, 4 H, CH2, COD), 1.86
(br m, 4 H, CH2, COD), 1.75 (br s, 10 H, CH2, COD and CH3,
N, 3.71; S, 8.50. Found: C, 54.01; H, 5.92; N, 3.42; S, 8.60.
Synthesis of [Ir(µ-tBu-PyS)(COD)]2 (2). Following the general
procedure, [Ir(µ-OMe)(COD)]2 (0.273 g, 0.413 mmol) and 6-tert-
butylpyridine-2-thiol (0.138 g, 0.826 mmol) were used to prepare
2 (0.328 g, 86%). 1H NMR (CDCl3, 300.13 MHz, 22 °C): δ 7.41
(t, J ) 7.8 Hz, 2 H, H4), 7.20 (d, J ) 7.7 Hz, 2 H, H3), 7.06 (d, J
) 7.8 Hz, 2 H, H5), 4.56 (br s, 8 H, dCH, COD), 2.17 (br m, 8 H,
CH2, COD), 1.70 (br m, 8 H, CH2, COD), 1.30 (s, 18 H, CH3,
tBu). 1H NMR (CDCl3, 300.13 MHz, -55 °C): δ 7.43 (t, J ) 7.8
Hz, 2 H, H4), 7.17 (d, J ) 7.7 Hz, 2 H, H3), 7.05 (d, J ) 7.7 Hz,
2 H, H5), 4.74 (br s, 4 H, dCH, COD), 4.26 (br s, 4 H, dCH,
COD), 2.21 (br s, 4 H, CH2, COD), 2.06 (br s, 4 H, CH2, COD),
1.81 (br m, 4 H, CH2, COD), 1.54 (br m, 4 H, CH2, COD), 1.26 (s,
t
tBu), 1.14 (br s, 13 H, CH2, COD and CH3, Bu). MS [FAB+ m/z
(%)]: 939 (73) [M+], 830 (9) [M+ - COD]. Anal. Calcd for
C32H50N4S2Ir2 (939.33): C, 40.92; H, 5.37; N, 5.96; S, 6.83.
Found: C, 40.81; H, 4.98; N, 5.90; S, 6.81.
Synthesis of [Rh(µ-tBu2-ImS)(COD)]2 (13). Following the
general procedure, [Rh(µ-OMe)(COD)]2 (0.116 g, 0.239 mmol) and
1,4-di-tert-butylimidazole-2-thiol (0.102 g, 0.479 mmol) were used
to prepare 13 (0.169 g, 84%). Two main species are observed by
NMR at RT in CD2Cl2: A (dinuclear) and B (mononuclear), in a
t
18 H, CH3, Bu). 13C{1H} APT NMR (CDCl3, 100.63 MHz, 25
°C): δ 169.6 (SC), 153.4 (C6), 136.2 (C5), 126.6 (C4), 117.0 (C3),
ratio of 85% to 15%. H NMR (CD2Cl2, 400.16 MHz, 25 °C),
1
t
65.1 (dCH, COD), 38.0 (C, Bu), 32.1 (CH2, COD), 30.1 (CH3,
selected resonances: δ 6.61 (br s, 2 H, H5, A), 6.21 (s, 1 H, H5,
B), 4.00-4.56 (br m, 8 H, dCH, COD, A), 1.56 (s, 9 H, N-tBu,
B), 1.08 (s, 9 H, tBu, B). 1H NMR (toluene-d8, 300.13 MHz, -60
°C): δ 6.63 (br m, 2 H, H5), 5.70 (br s, 4 H, dCH, COD), 4.42 (br
s, 4 H, dCH, COD), 3.71 (br s, 3 H, CH2, COD), 2.94 (br s, 3 H,
CH2, COD), 2.24 (br m, 5 H, CH2, COD), 1.80 (br m, 5 H, CH2,
COD), 1.54 (br s, 18 H, CH3, N-tBu), 1.37 (br s, 18 H, CH3, tBu).
MW: found 508 (calcd 844.8). MS [FAB+ m/z (%)]: 844 (11)
tBu). 13C{1H} APT NMR (CDCl3, 75.47 MHz, -55 °C): δ 169.2
(SC), 152.7 (C6), 136.2 (C5), 126.2 (C4), 116.8 (C3), 66.5 (dCH,
t
COD), 64.2 (dCH, COD), 37.8 (C, Bu), 32.1 (CH2, COD), 31.8
t
(CH2, COD), 29.8 (CH3, Bu). MW: found 934.4 (calcd 933.3).
MS [FAB+ m/z (%)]: 933 (36) [M]+, 824 (18) [M+ - COD]. Anal.
Calcd for C34H48N2S2Ir2 (933.32): C, 43.75; H, 5.18; N, 3.00; S,
6.87. Found: C, 43.45; H, 4.95; N, 2.92; S, 6.33.
t
[M+], 736 (47) [M+ - COD], 633 (63) [M+ - Bu2-ImS], 422
Synthesis of [Rh(µ-Me-tBu-ImS)(COD)]2 (7). Following the
general procedure, [Rh(µ-OMe)(COD)]2 (0.200 g, 0.413 mmol) and
1-methyl-4-tert-butylimidazole-2-thiol (0.140 g, 0.826 mmol) were
used to prepare 7 (0.258 g, 82%). 1H NMR (CD2Cl2, 400.16 MHz,
25 °C): δ 6.50 (s, 2 H, H5), 4.59 (br s, 8 H, dCH, COD), 3.45 (s,
6 H, N-CH3), 2.47 (br m, 8 H, CH2, COD), 1.93 (br m, 8 H, CH2,
(100) [M+ - Rh(tBu2-ImS)(COD)]. Anal. Calcd for C38H62N4S2-
Rh2 (844.86): C, 54.02; H, 7.40; N, 6.63; S, 7.59. Found: C, 53.94;
H, 7.00; N, 6.38; S, 7.41.
Synthesis of [Ir(µ-tBu2-ImS)(COD)]2 (14). Following the
general procedure, [Ir(µ-OMe)(COD)]2 (0.175 g, 0.264 mmol) and
1,4-di-tert-butylimidazole-2-thiol (0.112 g, 0.528 mmol) were used
to prepare 14 (0.249 g, 92%). 1H NMR (CD2Cl2, 400.16 MHz, 25
°C), selected resonances: δ 6.67 (s, unidentified isomer), 6.61 (s,
t
1
COD), 1.28 (s, 18 H, CH3, Bu). H NMR (CD2Cl2, 300.13 MHz,
-95 °C): δ 6.51 (s, 1 H, H5), 6.45 (s, 1 H, H5), 5.12 (br s, 1 H,
dCH, COD), 4.74 (br m, 3 H, dCH, COD), 4.09 (br m, 1 H, d